Anti-human very late antigen-alpha4 (CD49d) monoclonal antibody (BU49) cross-reacts with the canine B-cell leukemia cell line GL-1, resulting in the induction of homotypic cell aggregation.
Ikewaki
Nobunao
N
Department of Animal Pharmaceutical Science, Kyushu University of Health and Welfare School of Pharmaceutical Sciences, and Institute of Immunology, Takahashi Educational Institute, 1714-1 Yoshino-cho, Nobeoka, Miyazaki 882-8508, Japan. nikewaki@phoenix.ac.jp
Nakaichi
Munekazu
M
Mizuno
Takuya
T
Takamura
Norito
N
Tokunaga
Jin
J
Ogata
Kenji
K
Inoko
Hidetoshi
H
Otsu
Ryuichi
R
D008841:Actin Cytoskeleton / Q000276:immunology; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D002449:Cell Aggregation / Q000276:immunology*; D045744:Cell Line, Tumor; D017868:Cyclic AMP-Dependent Protein Kinases / Q000276:immunology / Q000378:metabolism; D004285:Dogs; D004492:Edetic Acid / Q000494:pharmacology; D006801:Humans; D039041:Integrin alpha4beta1 / Q000276:immunology*; D015448:Leukemia, B-Cell / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008297:Male; D011493:Protein Kinase C / Q000276:immunology / Q000378:metabolism; D020298:U937 Cells
D000911:Antibodies, Monoclonal; D039041:Integrin alpha4beta1; D004492:Edetic Acid; D017868:Cyclic AMP-Dependent Protein Kinases; D011493:Protein Kinase C